- Home
- / Aura Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Aura Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$10.7
2024-10-29
Market Capitalization
$544.2 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| General and administrative expense | 10.1M | 18.1M | 19.8M | 22.8M | 22.5M |
| Operating expense total | 60.3M | 85.0M | 96.1M | 112.8M | |
| EBIT | (35.2M) | (60.3M) | (85.0M) | (96.1M) | (112.8M) |
| Pre tax profit | (76.3M) | (86.8M) | (106.1M) | ||
| Income tax expense | 137.0K | 100.0K | 100.0K | ||
| Net Income | (35.3M) | (58.8M) | (76.4M) | (86.9M) | (106.2M) |
| EPS | (2.0) | (1.9) | (1.7) | (1.8) |